Michael Halstead
CIK 1521548 · President · last filed 2025-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
61
Lifetime Open-Market Net
-$33.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | President | 0 | $131.87 | $0 | -$33.09M | 43 | 2025-04-02 |
Recent Filings · Page 5 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-06 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-06 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +20,000 | $307.6K | EDGAR |
| 2014-07-31 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-10-01 | — | Disp (D) | −51,840 | $0 | |
| 2013-07-02 | — | Sell (S) | −366 | -$7.3K | |
| 2013-03-01 | — | Sell (S) | −1,747 | -$23.5K | |
| 2013-02-21 | — | Sell (S) | −419 | -$6.1K | |
| 2013-02-15 | — | Grant (A) | +15,470 | $0 | |
| 2013-02-04 | — | Sell (S) | −998 | -$14.1K | |
| 2013-01-31 | — | Sell (S) | −320 | -$4.3K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.